Aldeyra Therapeutics, Inc.
ALDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,688 | -$9,767 | -$9,930 | -$15,809 |
| Dep. & Amort. | $64 | $62 | $61 | $64 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $197 | $0 | $1,263 |
| Change in WC | -$1,761 | $1,332 | -$4,750 | $2,866 |
| Other Non-Cash | $2,365 | -$379 | $2,149 | -$421 |
| Operating Cash Flow | -$7,021 | -$8,555 | -$12,470 | -$12,037 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$24,554 | -$15,710 | -$21,564 |
| Inv. Sales/Matur. | $25,000 | $24,000 | $23,000 | $20,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $25,000 | -$554 | $7,290 | -$1,564 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$293 |
| Stock Issued | $121 | $0 | $1,003 | $300 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $121 | $0 | $1,003 | $8 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $18,099 | -$9,109 | -$4,176 | -$13,593 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41,241 | $50,351 | $54,527 | $68,120 |
| End Cash | $59,341 | $41,241 | $50,351 | $54,527 |
| Free Cash Flow | -$7,021 | -$8,555 | -$12,470 | -$12,037 |